Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke
Emma Martínez‐Alonso(Instituto Ramón y Cajal de Investigación Sanitaria), Alberto Alcázar(Instituto Cajal), Jaime Masjuán(Universidad de Alcalá), Rocío Fernández-Serra(Universidad Politécnica de Madrid), Daniel González‐Nieto(Cincinnati Children's Hospital Medical Center), Mourad Chioua(Instituto de Química Orgánica General), Alejandro Escobar-Peso(Instituto Ramón y Cajal de Investigación Sanitaria), Alicia Aliena‐Valero(Universitat de València), José Marco‐Contelles(Instituto de Salud Carlos III), Youness Ouahid, Germán Torregrosa(Universitat de València), Juan B. Salom(Universitat de València)
Cited by 12
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study
|European Journal of Neurology|2020|385
Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)
|The Lancet|2012|280
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
|Journal of Clinical Investigation|2005|257